Ethoxycarbonylmethyl)triphenylphosphonium bromide (Cas No.1530-45-6)

Ethoxycarbonylmethyl triphenylphosphonium bromide (CAS 1530-45-6) is a white crystalline phosphonium salt, a vital reagent in organic chemistry for forming carbon-carbon double bonds via the Wittig reaction, converting aldehydes/ketones to α,β-unsaturated esters by reacting with triphenylphosphine and ethyl bromoacetate; it serves as a precursor to stabilized ylides for synthesizing complex molecules like pharmaceuticals. About the Company GST Registration Date: 2023 Legal Status of Firm: Limited Company Number of Employees: Upto 10 People Annual Turnover: 5 - 25 Cr company-description: Symax Laboratories, established in the year 2015, is one of the leading manufacturers of the inert substances that help in delivering active ingredients necessary for the pharmaceutical industry, bulk drug formulations. Symax has proven technical and operational expertise in developing a wide range of pharmaceutical ingredients and fine chemicals.Symax Laboratories has developed 900+ products. supplying to over 650 customers in Telangana, Andhra Pradesh, Maharashtra, Delhi, Gujarat and West Bengal states of India since inception. Symax Laboratories emphasizes on investing and engaging their expert resources in research and development to meet the evolving needs of the pharmaceutical market. In pursuit of its mission, Symax is poised to expand its operations into broader territories and diversify its activities. Quality Continuous focus on maintaining quality in what we do, being innovative and designing solutions to meet the demand of the marketplace. Safety as a Priority Let every action at the workplace to ensure the safety of the employees, environment and community. Integrity Being honest and truthful. A personal choice to hold oneself accountable for moral and ethical standards. Excellence Good is not enough. Strive for excellence in everything we do to create value for our customers resulting in building trust. Collaborative Working Always stay connected with every stakeholder, team spirit with colleagues and partners, staying relevant and informed in our pursuit of success. Research & Development Our continuous efforts and investment in R&D that have most positively impacted in meeting the raw material needs of the pharmaceutical companies in India. Our current focus areas are on a wide range of reagents, derivatives, fine chemicals, dry solvents products much needed in the form of pharmaceutical ingredients. We are on a constant look out for new opportunities outside these areas to meet the newer requirements of the pharmaceutical companies. We believe in continuously creating a huge pipeline of products through our R&D efforts by applying our knowledge and expertise to grow exponentially.